|
Overrepresentation of MIPS functional categories in genes that were differentially transcribed in response to fully fermentative conditions. Clusters A&B, 2 & 3 and 4, 5 & 6 had similar expression pattern and similar enrichments, and were therefore pooled before the overrepresentation analysis. Enrichment was estimated by hypergeometric distribution analysis (cut-offs around 10-5, see Materials and Methods); magnitude of the enrichment is indicated by the p-value. |
||||||||
| MIPS_cat. |
A&B (283 genes) |
C (237 genes) |
D (87 genes) |
|||||
|
|
||||||||
| nr. |
description |
nr of genesa |
nr of genesb |
p-value |
nr of genesb |
p-value |
nr of genesb |
p-value |
|
|
||||||||
| 01 |
METABOLISM |
1531 |
38 |
3.8E-05 |
||||
| 01.01 |
amino acid metabolism |
243 |
28 |
2.6E-06 |
29 |
1.7E-08 |
||
| 01.01.06 |
metabolism of the aspartate family |
64 |
13 |
4.5E-07 |
||||
| 01.01.06.05.01 |
biosynthesis of methionine |
14 |
5 |
1.0E-04 |
||||
| 01.03 |
nucleotide metabolism |
230 |
23 |
6.3E-05 |
23 |
1.2E-05 |
||
| 01.03.01 |
purine nucleotide metabolism |
66 |
17 |
3.8E-09 |
||||
| 01.03.01.03 |
purine nucleotide anabolism |
29 |
13 |
7.4E-12 |
||||
| 01.05.01 |
C-compound and carbohydrate utilization |
510 |
18 |
1.4E-04 |
||||
| 01.05.01.07.03 |
tetrahydrofolate-dependent C-1-transfer |
14 |
6 |
5.8E-06 |
||||
|
|
||||||||
| 11 |
TRANSCRIPTION |
1036 |
126 |
9.4E-31 |
||||
| 11.02.01 |
rRNA synthesis |
56 |
12 |
4.4E-06 |
||||
| 11.02.02 |
tRNA synthesis |
39 |
9 |
3.8E-05 |
||||
| 11.04 |
RNA processing |
394 |
89 |
9.4E-42 |
||||
| 11.04.01 |
rRNA processing |
174 |
78 |
8.7E-62 |
||||
| 11.06 |
RNA modification |
65 |
19 |
2.1E-11 |
||||
| 11.06.01 |
rRNA modification |
17 |
9 |
1.0E-08 |
||||
|
|
||||||||
| 12 |
PROTEIN SYNTHESIS |
511 |
63 |
1.7E-14 |
103 |
7.6E-53 |
||
| 12.01 |
ribosome biogenesis |
343 |
49 |
8.5E-14 |
89 |
1.0E-54 |
||
| 12.01.01 |
ribosomal proteins |
277 |
88 |
1.8E-62 |
||||
|
|
||||||||
| 14 |
PROTEIN FATE (folding, modification, destination) |
|||||||
| 14.07.02 |
modification with sugar residues |
70 |
8 |
4.1E-06 |
||||
| 14.07.02.01 |
O-directed glycosylation |
16 |
4 |
5.2E-05 |
||||
|
|
||||||||
| 16 |
PROTEIN WITH BINDING FUNCTION |
1049 |
82 |
4.6E-08 |
||||
| 16.03 |
nucleic acid binding |
346 |
47 |
2.0E-12 |
||||
| 16.03.03 |
RNA binding |
194 |
31 |
2.8E-10 |
||||
|
|
||||||||
| 20 |
CELLULAR TRANSPORT, TRANSPORT FACILITATION... |
1038 |
||||||
| 20.01.13 |
lipid transport |
43 |
5 |
3.3E-05 |
||||
| MIPS_cat. |
1 (120 genes) |
2 & 3 (577 genes) |
4, 5 & 6 (617 genes) |
|||||
|
|
||||||||
| nr. |
description |
nr of genesa |
nr of genesb |
p-value |
nr of genesb |
p-value |
nr of genesb |
p-value |
|
|
||||||||
| 01 |
METABOLISM |
1531 |
193 |
4.3E-08 |
192 |
1.3E-05 |
||
| 01.05 |
C-compound and carbohydrate metabolism |
510 |
89 |
2.6E-10 |
80 |
4.9E-06 |
||
| 01.05.01.01.01 |
sugar, glucoside, polyol and carboxylate catabolism |
82 |
27 |
4.7E-09 |
||||
| 01.06 |
lipid, fatty acid and isoprenoid metabolism |
292 |
55 |
6.6E-07 |
||||
| 01.06.01.07 |
isoprenoid metabolism |
41 |
14 |
1.6E-05 |
||||
| 01.06.01.07.11 |
tetracyclic and pentacyclic triterpenes biosynthesis |
36 |
13 |
1.6E-05 |
||||
|
|
||||||||
| 02 |
ENERGY |
360 |
112 |
5.1E-35 |
69 |
1.1E-08 |
||
| 02.10 |
tricarboxylic-acid pathway |
31 |
11 |
4.7E-05 |
12 |
1.5E-05 |
||
| 02.11 |
electron transport & membrane-ass. energy conservation |
54 |
30 |
4.2E-18 |
||||
| 02.13 |
Respiration |
131 |
53 |
1.1E-22 |
||||
| 02.13.03 |
aerobic respiration |
74 |
38 |
5.2E-21 |
||||
| 02.19 |
metabolism of energy reserves |
53 |
16 |
2.4E-05 |
||||
| 02.25 |
oxidation of fatty acids |
9 |
6 |
3.5E-05 |
||||
| 02.45.15 |
energy generation (e.g. ATP synthase) |
18 |
9 |
1.5E-05 |
||||
|
|
||||||||
| 11 |
TRANSCRIPTION |
|||||||
| 11.02.03.04.01 |
transcriptional activator |
42 |
7 |
1.2E-05 |
||||
|
|
||||||||
| 14 |
PROTEIN FATE (folding, modific., destination) |
1167 |
173 |
1.6E-08 |
||||
| 14.07.11 |
protein processing (proteolytic) |
92 |
24 |
4.1E-07 |
||||
| 14.13 |
protein degradation |
264 |
61 |
3.6E-11 |
||||
| 14.13.01 |
cytoplasmic and nuclear protein degradation |
194 |
48 |
4.2E-10 |
||||
| 14.13.01.01 |
proteasomal degradation |
134 |
33 |
2.8E-07 |
||||
|
|
||||||||
| 20 |
CELLULAR TRANSPORT, TRANSPORT FAC. |
1028 |
||||||
| 20.01.15 |
electron/hydrogen transport |
76 |
24 |
2.3E-08 |
||||
| 20.09 |
transport routes |
695 |
98 |
4.2E-05 |
||||
|
|
||||||||
| 32 |
CELL RESCUE, DEFENSE AND VIRULENCE |
559 |
77 |
7.4E-05 |
||||
| 32.01 |
stress response |
454 |
73 |
4.2E-07 |
||||
| 32.01.01 |
oxydative stress response |
56 |
18 |
10E-06 |
||||
| 32.01.07 |
unfolded protein response (ER quality control) |
74 |
16 |
7.6E-04 |
||||
|
|
||||||||
| 42 |
BIOGENESIS OF CELL. COMPONENTS |
|||||||
| 42.16 |
mitochondrion |
170 |
38 |
9.0E-08 |
35 |
1.1E-05 |
||
|
a: amount of genes in the genome belonging to the specified functional category b: amount of genes in the respective clusters or group of clusters belonging to the specified functional category | ||||||||
van den Brink et al. BMC Genomics 2008 9:100 doi:10.1186/1471-2164-9-100 |
||||||||